Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
Preoperative bevacizumab and chemotherapy may benefit a subset of breast cancer (BC) patients. To explore potential mechanisms of this benefit, we conducted a phase II study of neoadjuvant bevacizumab (single dose) followed by combined bevacizumab and adriamycin/cyclophosphamide/paclitaxel chemother...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | , |
Format: | Article |
Language: | English |
Published: |
National Academy of Sciences (U.S.),
2017-05-04T22:31:51Z.
|
Subjects: | |
Online Access: | Get fulltext |